British Health Minister Matt Hancock said the data also shows that the vaccines work.

Coronavirus – the second year

It has been more than a year since the Chinese authorities informed the WHO of the emergence of a new, rapidly spreading virus. Since then, there has hardly been a person in the world who has not heard the term Covid-19, and more and more people are mourning a family member or friend with whom the new disease ended as stocks collapsed in weeks and our entire lives were rewritten. by the epidemic. By now, the vaccines have been completed, which in turn raises not only hope, but again a lot of questions, while not only stopping the virus, but also threatening another mutation. You will find the details of this fight in our series of articles.

A vaccine developed jointly by the University of Oxford and AstraZeneca and Pfizer and BioNTech said a study by British experts released Monday.

even after a single dose, they are very effective in preventing the development of severe Covid-19 hospitalization in coronavirus-infected elderly.

A first dose of the Oxford / AstraZeneca and Pfizer / BioNTech vaccine in people over the age of 80 was more than 80 percent effective in both the third and fourth weeks after administration, according to a study published Monday night by the Public Health Service (PHE). .the severity of the illness requiring hospitalization of the patient.

The PHE study also showed that the Pfizer / BioNTech vaccine, which was launched in the UK a month earlier than the Oxford / AstraZeneca vaccine, reduced the number of deaths from the Covid-19 disease by 83% in those over 80 years of age. . the first dose.

According to British Health Secretary Matt Hancock, the number of deaths in older people vaccinated against the coronavirus is now declining faster than in younger populations who have not yet been vaccinated. According to a report from the Ministry of Health on Monday night, 20,275,451 have so far received the first dose of the coronavirus vaccine, and the second dose has been administered to 815,816 people. The number of first and second doses administered on this basis has exceeded 21 million in the UK.

If you ever want to know about similar things, check out the Facebook page in the HVG Tech section.



The number of independent publishing offices of power is steadily declining, and those that still exist are trying to stay afloat with a growing headwind. At HVG we persevere, we do not give in to pressure and we bring national and international news every day.

That is why we ask you, our readers, to support us, support us, join our membership and renew it!

And we promise to continue to do our best for you in all circumstances!